| 1 |
2022 |
Anna Wrobeln, Tristan Leu, Jadwiga Jablonska, Urban Geisthoff, Stephan Lang, Joachim Fandrey, Freya Droege. Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia, Scientific Reports. 2022; 12: 5877.
https://doi.org/10.1038/s41598-022-09759-9 |
| 2 |
2020 |
Carmelo Bernabeu, Pinar Bayrak-Toydemir, Jamie McDonald, Michelle Letarte. Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia, Journal of Clinical Medicine. 2020; 9: 3571.
https://doi.org/10.3390/jcm9113571 |
| 3 |
2022 |
Sophie Dupuis-Girod, Claire L. Shovlin, Anette D. Kjeldsen, Hans-Jurgen Mager, Carlo Sabba, Freya Droege, Anne-Emmanuelle Fargeton, Annette D. Fialla, Silvia Gandolfi, Ruben Hermann, Gennaro M. Lenato, Guido Manfredi, Marco C. Post, Catherine Rennie, Patrizia Suppressa, Ulrich Sure, Elisabetta Buscarini, Claudia Crocione, Ria Blom, Luisa Maria Botella, Fernando Brocca, Caroline Coxall, Karen T. Druckman, Didier Erasme, Paolo Federici, Christina Grabowski, Mildred Lundgren, Tone Søderman, Dara Woods. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?, European Journal of Medical Genetics. 2022; 65: 104575104575.
https://doi.org/10.1016/j.ejmg.2022.104575 |
| 4 |
2024 |
Evan Paul Tracy, Iyanujesu Adereti, Justin Chu, Julianna Brown. Hereditary haemorrhagic telangiectasia type 1 complicated by recurrent deep-seated MSSA infections necessitating lifelong antibiotic suppression, BMJ Case Reports. 2024; 17: e258558.
https://doi.org/10.1136/bcr-2023-258558 |
| 5 |
2022 |
Helen M. Arthur, Beth L. Roman. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms, Frontiers in Medicine. 2022; 9: 973964.
https://doi.org/10.3389/fmed.2022.973964 |
| 6 |
2021 |
Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Miguel Pericacho. Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?, Cancers. 2021; 13: 1552.
https://doi.org/10.3390/cancers13071552 |
| 7 |
2023 |
Yves Schild, Jonah Bosserhoff, Freya Droege, Elisabeth Littwitz-Salomon, Joachim Fandrey, Anna Wrobeln. Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia, Life. 2023; 13: 1708.
https://doi.org/10.3390/life13081708 |
| 8 |
2024 |
David C Lauzier, Anja I Srienc, Ananth K Vellimana, Ralph G Dacey Jr, Gregory J Zipfel. Peripheral macrophages in the development and progression of structural cerebrovascular pathologies, Journal of Cerebral Blood Flow & Metabolism. 2024; 44: 169.
https://doi.org/10.1177/0271678X231217001 |
